<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7595211</article-id><article-id pub-id-type="publisher-id">74558</article-id><article-id pub-id-type="doi">10.1038/s41598-020-74558-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Current and historic HIV-1 molecular epidemiology in paediatric and adult population from Kinshasa in the Democratic Republic of Congo</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Rubio-Garrido</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Gonz&#x000e1;lez-Alba</surname><given-names>Jos&#x000e9; Mar&#x000ed;a</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Reina</surname><given-names>Gabriel</given-names></name><address><email>gabi@unav.es</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ndarabu</surname><given-names>Adolphe</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Barqu&#x000ed;n</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Carlos</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Gal&#x000e1;n</surname><given-names>Juan Carlos</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Holgu&#x000ed;n</surname><given-names>&#x000c1;frica</given-names></name><address><email>africa.holguin@salud.madrid.org</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411347.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 9248 5770</institution-id><institution>HIV-1 Molecular Epidemiology Laboratory, Microbiology and Parasitology Department, </institution><institution>Hospital Ram&#x000f3;n y Cajal-IRYCIS and CIBEREsp-RITIP, </institution></institution-wrap>28034 Madrid, Spain </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411347.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 9248 5770</institution-id><institution>Virology Section, Microbiology and Parasitology Department, </institution><institution>Hospital Ram&#x000f3;n y Cajal-IRYCIS and CIBEREsp, </institution></institution-wrap>28034 Madrid, Spain </aff><aff id="Aff3"><label>3</label>Microbiology Department, Cl&#x000ed;nica Universidad de Navarra, Navarra Institute for Health Research (IdiSNA), Institute of Tropical Health, Universidad de Navarra (ISTUN), 31008 Pamplona, Spain </aff><aff id="Aff4"><label>4</label>Monkole Hospital, Kinshasa, Democratic Republic of the Congo </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.5924.a</institution-id><institution-id institution-id-type="ISNI">0000000419370271</institution-id><institution>Department of Preventive Medicine and Public Health, </institution><institution>Navarra Institute for Health Research (IdiSNA), Institute of Tropical Health, Universidad de Navarra (ISTUN), </institution></institution-wrap>Pamplona, 31008 Spain </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>10</volume><elocation-id>18461</elocation-id><history><date date-type="received"><day>5</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>30</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">HIV-1 diversity may impact monitoring and vaccine development. We describe the most recent data of HIV-1 variants and their temporal trends in the Democratic Republic of Congo (DRC) from 1976 to 2018 and in Kinshasa from 1983&#x02013;2018. HIV-1 <italic>pol</italic> sequencing from dried blood collected in Kinshasa during 2016&#x02013;2018 was done in 340 HIV-infected children/adolescents/adults to identify HIV-1 variants by phylogenetic reconstructions. Recombination events and transmission clusters were also analyzed. Variant distribution and genetic diversity were compared to historical available <italic>pol</italic> sequences from the DRC in Los Alamos Database (LANL). We characterized 165 HIV-1 <italic>pol</italic> variants circulating in Kinshasa (2016&#x02013;2018) and compared them with 2641 LANL sequences from the DRC (1976&#x02013;2012) and Kinshasa (1983&#x02013;2008). During 2016&#x02013;2018 the main subtypes were A (26.7%), G (9.7%) and C (7.3%). Recombinants accounted for a third of infections (12.7%/23.6% Circulant/Unique Recombinant Forms). We identified the first CRF47_BF reported in Africa and four transmission clusters. A significant increase of subtype A and sub-subtype F1 and a significant reduction of sub-subtype A1 and subtype D were observed in Kinshasa during 2016&#x02013;2018 compared to variants circulating in the city from 1983 to 2008. We provide unique and updated information related to HIV-1 variants currently circulating in Kinshasa, reporting the temporal trends of subtypes/CRF/URF during 43&#x000a0;years in the DRC, and providing the most extensive data on children/adolescents.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Virology</kwd><kwd>DNA recombination</kwd><kwd>Molecular evolution</kwd><kwd>Phylogeny</kwd><kwd>Evolution</kwd><kwd>Microbiology</kwd><kwd>Molecular biology</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003425</institution-id><institution>Departamento de Educaci&#x000f3;n, Gobierno de Navarra</institution></institution-wrap></funding-source><award-id>045-2015</award-id><award-id>045-2015</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004587</institution-id><institution>Instituto de Salud Carlos III</institution></institution-wrap></funding-source><award-id>PI16/01908</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par3">Several independent zoonotic transmission events from primates to humans around the beginning of the twentieth century<sup><xref ref-type="bibr" rid="CR1">1</xref></sup> in Central and West Africa gave rise to Acquired Immune Deficiency Syndrome (AIDS) in the human population, spreading quickly worldwide<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. The HIV epidemic is the result of two types of viruses: HIV-1 and HIV-2, which are closely related to SIV<sub><italic>ptt</italic></sub> and SIV<sub><italic>sm</italic></sub> respectively<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. HIV-1 causes most HIV infections worldwide and has been divided into 4 groups (M, N, O and P)<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref></sup>, but the global HIV epidemic is related to group M, which has been subdivided into 10 subtypes (A-D, F&#x02013;H, J-L)<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>, at least 100 Circulating Recombinant Forms (CRF)<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> and uncountable Unique Recombinant Forms (URF). HIV-1 diversity occurred in the early steps in the human adaptation of SIV<sub><italic>ptt</italic></sub><sup><xref ref-type="bibr" rid="CR12">12</xref></sup>.</p><p id="Par4">Since HIV-1 variability can impact transmission, pathogenesis and disease progression<sup><xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref></sup>, HIV monitoring<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>, resistance pathways<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, cognitive impairment<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, and HIV vaccine development<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, an accurate HIV-1 variant identification is needed<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. It can enable a better understanding of global HIV expansion<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup> and to infer the evolutionary possibilities in the selection of new variants, such as the recently described subtype L<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. HIV-1 molecular surveillance studies are globally important and of interest in any setting. However, it is more interesting to analyze HIV molecular diversity in an area with a high viral diversity, especially if the place is the origin of a HIV-1 pandemic, where the virus has been circulating for a longer period and new, more pathogenic or transmissible variants could have arised. HIV-1 pandemic originated in Central Africa<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, specifically in the DRC, Kinshasa being the epicenter<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>, spreading to neighboring cities or countries<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.</p><p id="Par5">The most ancestral available HIV-1 sequences were recovered from Kinshasa in 1959 (ZR59, near the ancestral node of subtypes B and D)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, 1960 (DRC60, subtype A)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup> and 1966, (DRC66, subtype C)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Subtype B also emerged in Kinshasa and was introduced into the Caribbean region via Haiti around 1966 by human migration and later disseminated to other regions, such as the United States of America, Europe, Asia, Latin America, and Australia<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>.</p><p id="Par6">Accordingly, Kinshasa is one of the most relevant places to carry out surveillance programs to increase the knowledge of HIV molecular epidemiology and viral evolution. In that context, our study presents the most recent data related to current circulating HIV-1 variants in <italic>pol</italic> in Kinshasa during the 2016&#x02013;2018 period, identifying transmission clusters and updating the genetic diversity. In addition, we present a complete review of HIV-1 variant trends in the DRC over 43&#x000a0;years (1976&#x02013;2018) after using all the historical <italic>pol</italic> sequences available in Los Alamos HIV Sequence Database (LANL) from samples collected in the DRC. We reclassified all HIV-1 variants after new phylogenetic analysis in all downloaded <italic>pol</italic> sequences, including the most recent subtype L and new CRF described in the last years. Later we studied the temporal trends of HIV-1 variants in the DRC and Kinshasa considering the sampling year of each sequence.</p></sec><sec id="Sec2"><title>Results</title><sec id="Sec3"><title>Current update of HIV molecular epidemiology in the DRC</title><p id="Par7">We obtained viral <italic>pol</italic> sequences (115 protease, PR, 139 retrotranscriptase, RT and 115 integrase, IN) from 165 (48.5%) of 340 HIV-infected children/adolescents (55, 33.3%) and adults (110, 66.7%) from two hospitals in Kinshasa (DRC) with dried blood specimens (DBS) collected during 2016&#x02013;2018 (Table <xref rid="Tab1" ref-type="table">1</xref>). Thus, our study was done in 165 patients with available <italic>pol</italic> sequence. The median age [IQR] at DBS collection for children and adults was 14.4 [11.4&#x02013;16.8] and 43 [34&#x02013;53.5] years old, respectively. Around 75% of subjects with available <italic>pol</italic> sequence were under antiretroviral treatment (ART) and 8 out of 10 presented more than 1000 HIV-1 RNA copies/ml at sampling (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Main characteristics of HIV-1 infected population from Kinshasa (DRC) with collected DBS in 2016&#x02013;2018.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">
Children/adolescents (%)
</th><th align="left">
Adults (%)
</th><th align="left">
Total (%)
</th></tr></thead><tbody><tr><td align="left">
Subjects with <italic>pol</italic> sequence
</td><td align="left">
55 (33.3)
</td><td align="left">
110 (66.7)
</td><td align="left">
165 (100)
</td></tr><tr><td align="left">
Female
</td><td align="left">
28 (50.9)
</td><td align="left">
64 (58.2)
</td><td align="left">
92 (55.8)
</td></tr><tr><td align="left">
Age at DBS collection (years), median [IQR]
</td><td align="left">14.4 [11.4&#x02013;16.8]</td><td align="left">
43 [34&#x02013;53.5]
</td><td align="left">
32.4 [16.2&#x02013;48.5]
</td></tr><tr><td align="left" colspan="4"><bold>ART exposure</bold></td></tr><tr><td align="left">
ARV naive
</td><td align="left">
0
</td><td align="left">
11 (10)
</td><td align="left">
11 (6.7)
</td></tr><tr><td align="left">
ART
</td><td align="left">
55 (100)
</td><td align="left">
69 (62.7)
</td><td align="left">
124 (75.2)
</td></tr><tr><td align="left">
Unknown
</td><td align="left">
0
</td><td align="left">
30 (27.3)
</td><td align="left">
30 (18.2)
</td></tr><tr><td align="left" colspan="4"><bold>HIV-1 viraemia&#x0003e;1000 HIV-1-RNA copies at sampling (data known in 55 children and in 103 adults)</bold></td></tr><tr><td align="left">
In 1 DBS dot [range]
</td><td align="left"><p>
19/55 (34.5)
</p><p>
[1260&#x02013;16,700]
</p></td><td align="left"><p>
51/103 (49.5)
</p><p>
[1200&#x02013;132,000]
</p></td><td align="left"><p>
70 (42.4)
</p><p>
[1200&#x02013;132,000]
</p></td></tr><tr><td align="left">
In 1 ml plasma* [range]
</td><td align="left"><p>49/55 (89.1)
</p><p>
[1351&#x02013;469,320]
</p></td><td align="left"><p>
86/103 (83.5)
</p><p>
[1008&#x02013;3,901,478]
</p></td><td align="left"><p>
135 (81.8)
</p><p>
[1008&#x02013;3,901,478]
</p></td></tr><tr><td align="left" colspan="4"><bold>Available</bold>
<bold><italic>pol</italic></bold>
<bold>HIV-1 sequences</bold></td></tr><tr><td align="left">
PR
</td><td align="left">36 (65.5)</td><td align="left">
79 (71.8)
</td><td align="left">
115 (69.7)
</td></tr><tr><td align="left">
RT
</td><td align="left">49 (89.1)</td><td align="left">
90 (81.8)
</td><td align="left">
139 (84.2)
</td></tr><tr><td align="left">
IN
</td><td align="left">40 (72.7)</td><td align="left">
75 (68.2)
</td><td align="left">
115 (69.7)
</td></tr><tr><td align="left" colspan="4"><bold>Combination of sequences by regions</bold>
</td></tr><tr><td align="left">
Only PR
</td><td align="left">0</td><td align="left">
1 (0.9)
</td><td align="left">
1 (0.6)
</td></tr><tr><td align="left">
Only RT
</td><td align="left">5 (9.1)</td><td align="left">
8 (7.3)
</td><td align="left">
13 (7.9)
</td></tr><tr><td align="left">
Only IN
</td><td align="left">6 (10.9)</td><td align="left">
19 (17.3)
</td><td align="left">
25 (15.1)
</td></tr><tr><td align="left">
PR+RT
</td><td align="left">10 (18.2)</td><td align="left">
26 (23.6)
</td><td align="left">
36 (21.8)
</td></tr><tr><td align="left">
RT+IN
</td><td align="left">8 (14.5)</td><td align="left">
4 (3.6)
</td><td align="left">
12 (7.3)
</td></tr><tr><td align="left">
PR+RT+IN
</td><td align="left">26 (47.3)</td><td align="left">
52 (47.3)
</td><td align="left">
78 (47.3)
</td></tr><tr><td align="left" colspan="4"><bold>HIV-1 variants at</bold>
<bold><italic>pol</italic></bold></td></tr><tr><td align="left">
Subtype B
</td><td align="left">
1 (1.8)
</td><td align="left">
0
</td><td align="left">
1 (0.6)
</td></tr><tr><td align="left">
Non-B subtypes
</td><td align="left">
28 (50.9)
</td><td align="left">
70 (62.4)
</td><td align="left">
98 (59.4)
</td></tr><tr><td align="left">
CRF
</td><td align="left">
2 (3.6)
</td><td align="left">
19 (17)
</td><td align="left">
21 (12.7)
</td></tr><tr><td align="left">
URF
</td><td align="left">
22 (40)
</td><td align="left">
17 (14.5)
</td><td align="left">
39 (23.7)
</td></tr><tr><td align="left">
U
</td><td align="left">
2 (3.6)
</td><td align="left">
4 (3.6)
</td><td align="left">
6 (3.6)
</td></tr></tbody></table><table-wrap-foot><p>DRC, Democratic Republic of Congo; DBS, dried blood specimens; ART, antiretroviral treatment; ARV, antiretroviral drugs; PR, protease; RT, retrotranscriptase; IN, integrase; <italic>pol</italic>, HIV-1 <italic>pol</italic> coding region; CRF, circular recombinant forms; URF, unique recombinants forms; U, unknown variant, not ascribed to pure subtype, CRF or URF.</p><p>*Estimated HIV-1-RNA copies considering hematocrit<sup><xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR71">71</xref></sup>.</p></table-wrap-foot></table-wrap></p><p id="Par8">From the historical database, we recovered&#x000a0;5672&#x000a0;group M&#x000a0;<italic>pol</italic> sequences without gaps or ambiguities available in LANL, 4090&#x000a0;of them being assigned to HIV-1 pure subtypes (300&#x000a0;A, 2476 B, 1133 C, 72 D, 48 F, 45 G, 7 H, 5&#x000a0;J, 1&#x000a0;K, 3 L) and&#x000a0;1582 circulating recombinants forms CRF_01 to CRF_99. As expected, most (99.4%) viral sequences from the 165 subjects were classified as HIV-1 non-B variants in <italic>pol</italic> coding region. Among them, 59.4% were 9 pure non-B subtypes, 36.4% recombinant forms (23.7% URFs and 12.7% CRFs) and 3.6% unique unclassificable (U) sequences. The most frequent HIV-1 variant was subtype A (26.7%), followed by subtypes G (9.7%) and C (7.3%) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and Sup. Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>). The most prevalent CRF were CRF45_cpx (2.4%), CRF02_AG (1.8%) and CRF27_cpx (1.8%) in our cohort. Interestingly, we identified for the first time the CRF47_BF variant in the DRC, infecting an 8&#x000a0;year-old child. Among recombinant forms, URF accounted for 65% of infections in our study cohort (2016&#x02013;2018). These URF were in circulation in Kinshasa during 2016&#x02013;2018. Recombination patterns in the analyzed <italic>pol</italic> fragments assigned to URF among the 39 subjects is described in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. When specific HIV-1 variants were compared between age groups, adults presented a greater number of different CRF (11 variants) than children/adolescent group (2 CRF: CRF27_cpx and CRF47_BF). Althought the children/adolescent group presented less diversity, they had almost 3 times as many URF infections than adults (40% vs. 14.5%; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). The rate of pure subypes was similar across both groups.<fig id="Fig1"><label>Figure 1</label><caption><p>Current molecular epidemiology characterization in our HIV-1 study cohort from Kinshasa (DRC) with collected DBS in 2016&#x02013;2018. Percentages calculated considering new HIV-1 <italic>pol</italic> sequences recovered from DBS of 165 HIV-1 infected subjects from Kinshasa during 2016&#x02013;2018.</p></caption><graphic xlink:href="41598_2020_74558_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>Recombination structure of the available <italic>pol</italic> sequences assigned to URF and recovered from 39 HIV-1 infected subjects in Kinshasa (2016&#x02013;2018). This figure represents a simplified URF structure. In bold, viruses collected from adults. The remaining, viruses collected from children/adolescents.</p></caption><graphic xlink:href="41598_2020_74558_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec4"><title>Cluster identification between non-epidemiologically related adults and children/adolescents</title><p id="Par10">Among the 165 <italic>pol</italic> sequences from Kinshasa we identified 4 independent transmission clusters (Table <xref rid="Tab2" ref-type="table">2</xref> and Sup. Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>&#x02013;<xref rid="MOESM1" ref-type="media">5</xref>) supported by 100% bootstrap, presenting recent transmission (genetic distance lower than 0.01) in three of them: cluster 1, cluster 3 and cluster 4. Infected individuals from clusters 1, 2 and 3 carried subtype A <italic>pol</italic> sequences, although they were not ascribed to previously characterized sub-subtypes A or CRF including A at <italic>pol</italic> coding region. They appeared in 3 different branches in PhyML trees after including all LANL sequences ascribed to subtype A and their sub-subtypes circulating in the DRC since 1976 (Sup. Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>&#x02013;<xref rid="MOESM1" ref-type="media">4</xref>). Subjects from cluster 4 harbored subtype H viruses, clustering apart from other subtype H LANL sequences from the DRC (Sup. Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5</xref>). Table <xref rid="Tab2" ref-type="table">2</xref> shows the epidemiological data collected from clinical reports of each patient. All clusters included 2 subjects, except cluster 1 including a 34.7&#x000a0;year-old woman, a 6.2&#x000a0;year-old boy and a 14.3&#x000a0;year-old adolescent male with no reported epidemiological link (Sup. Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>). Clusters 2 and 3 included two adults and cluster 4 two children.</p><p id="Par9"><table-wrap id="Tab2"><label>Table 2</label><caption><p>Clusters identification in the studied population from Kinshasa in the 2016&#x02013;2018 period.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Cluster n&#x000ba;</th><th align="left" colspan="4">Patients data</th><th align="left" colspan="5">Cluster data</th></tr><tr><th align="left">Involved subjects</th><th align="left">Group of age</th><th align="left">Age at sampling</th><th align="left">Gender</th><th align="left">HIV-1 variant</th><th align="left">Analized&#x000a0;nts</th><th align="left">Bootstrap (%)</th><th align="left">Genetic distance**</th><th align="left">PhyML tree</th></tr></thead><tbody><tr><td align="left" rowspan="3">1</td><td align="left">16.RDC_P33</td><td align="left">Adolescent</td><td char="." align="char">14.3</td><td align="left">M</td><td align="left" rowspan="3">A*</td><td char="." align="char" rowspan="3">1270</td><td char="." align="char" rowspan="3">100</td><td char="." align="char" rowspan="3">0.02***</td><td align="left" rowspan="3">Sup.Fig <xref rid="MOESM1" ref-type="media">2</xref></td></tr><tr><td align="left">18.RDC_P64</td><td align="left">Child</td><td char="." align="char">6.2</td><td align="left">M</td></tr><tr><td align="left">18.CUN288</td><td align="left">Adult</td><td char="." align="char">34.7</td><td align="left">F</td></tr><tr><td align="left" rowspan="2">2</td><td align="left">16.CUN24</td><td align="left">Adult</td><td char="." align="char">57.7</td><td align="left">F</td><td align="left" rowspan="2">A*</td><td char="." align="char" rowspan="2">1279</td><td char="." align="char" rowspan="2">100</td><td char="." align="char" rowspan="2">0.05</td><td align="left" rowspan="2">Sup.Fig <xref rid="MOESM1" ref-type="media">3</xref></td></tr><tr><td align="left">16.CUN82</td><td align="left">Adult</td><td char="." align="char">62.3</td><td align="left">M</td></tr><tr><td align="left" rowspan="2">3</td><td align="left">16.CUN28</td><td align="left">Adult</td><td char="." align="char">50.6</td><td align="left">F</td><td align="left" rowspan="2">A*</td><td char="." align="char" rowspan="2">649</td><td char="." align="char" rowspan="2">100</td><td char="." align="char" rowspan="2">0.003</td><td align="left" rowspan="2">Sup.Fig <xref rid="MOESM1" ref-type="media">4</xref></td></tr><tr><td align="left">16.CUN32</td><td align="left">Adult</td><td char="." align="char">37.6</td><td align="left">F</td></tr><tr><td align="left" rowspan="2">4</td><td align="left">16.RDC_P3</td><td align="left">Child</td><td char="." align="char">10.2</td><td align="left">M</td><td align="left" rowspan="2">H</td><td char="." align="char" rowspan="2">1269</td><td char="." align="char" rowspan="2">100</td><td char="." align="char" rowspan="2">0.005</td><td align="left" rowspan="2">Sup.Fig <xref rid="MOESM1" ref-type="media">5</xref></td></tr><tr><td align="left">17.RDC_P49</td><td align="left">Child</td><td char="." align="char">9.7</td><td align="left">F</td></tr></tbody></table><table-wrap-foot><p>Nts, nucleotides; Sup, supplementary; Fig, figure; M, male; F, female.</p><p>*Subtype A sequences not ascribed to previously characterized sub-subtypes A or CRF including A at <italic>pol </italic>coding region recovered from patients in the DRC with available LANL sequences.</p><p>**We considered recent transmission when genetic distance was lower than 0.01.</p><p>***Genetic distance &#x0003c;0.01 comparing P64 and CUN288.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>Transmission networks involved a common recombinant fragment in recent paediatric/adolescents sequences from Kinshasa</title><p id="Par11">Among the 165 new sequences (2016&#x02013;2018), we found the presence of a transmission network, including two different clusters (RecG and RecB) of 17 viruses sharing one<italic>&#x000a0;pol</italic>&#x000a0;fragment (Table <xref rid="Tab3" ref-type="table">3</xref> and Sup. Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6</xref>). Interestingly, all viruses involved were collected from paediatric patients with no epidemiological linkage according to clinical reports. Cluster RecB included viruses sharing&#x000a0;a&#x000a0;fragment of 599 nt in RT (positions&#x000a0;2935&#x02013;3534&#x000a0;in HXB2) assigned to subtype B, in&#x000a0;8 patients ranging from 9 to 18&#x000a0;years-old. Cluster RecG included viruses from 9 adolescents from 10 to 19&#x000a0;years-old sharing a fragment in IN (positions&#x000a0;4390&#x02013;5005&#x000a0;in HXB2) of 615 nt assigned to subtype G (Table <xref rid="Tab3" ref-type="table">3</xref>).&#x000a0;Of note, one <italic>pol&#x000a0;</italic>sequence from a 19&#x000a0;year-old female (18.RDC_P83) shared fragments of both clusters (Sup. Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6</xref>).&#x000a0;The common progenitor viruses for clusters RecG and RecB using PhyML trees were not found in all 2802 LANL sequences from the DRC. We also observed a recombination event at protease coding region involving viruses from 2 adults (subtype A, CUN131 and subtype H, CUN127), leading to URF_A virus infecting CUN123 (Sup. Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Description of recombination transmission net found among the 165 HIV-1 variants collected in Kinshasa from 2016 to 2018.</p></caption><graphic position="anchor" xlink:href="41598_2020_74558_Tab3_HTML" id="MO15"/><table-wrap-foot><p>RecB, recombination network sharing 599&#x000a0;nts subtype B fragment in RT; RecG, recombination network sharing 615&#x000a0;nts subtype G fragment in IN; M, male; F, female; frag., fragment. Analysed <italic>pol</italic> fragment (numbering according to HXB2): 1, positions 2253-2934 (in protease); 2, positions 2935-3534 (in retrotranscriptase); 3, positions 3704-4389 (in RNase H); 4, positions 4390-5005 (in integrase).</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec6"><title>Reclassification of HIV-1 variants with LANL sequence circulating in the DRC since 1976</title><p id="Par12">In order to increase the number of <italic>pol</italic> sequences from the DRC, we downloaded all 2802 available <italic>pol</italic> sequences in LANL, which had been collected since 1976 to 2012, mainly (99.9%) from adults (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Then, since new HIV-1 variants have appeared in the recent years, we reclassified the 2641 pure subtypes and CRF, excluding 161 URF, performing the same PhyML analysis and reference sequences set in the historic LANL database from the DRC as in our sequences collected in Kinshasa from 2016&#x02013;2018. Interestingly, we found some discrepancies in the HIV-1 variant classification in 8.8% (198 sub-subtype A1 and 34 U) of them, which had probably been misclassified due to less available reference HIV-1 sequences and to the absence of new subtypes and new CRF when they were classified. The new PhyML analysis revealed that 198 (32.9%) of the 602 sequences originaly appointed as sub-subtype A1 in LANL were, in fact, other HIV-1 variants, 101 being subtype A (51%), 88 CRF02_AG (44.4%), 3 CRF11_cpx (1.5%), 3 CRF25_cpx (1.5%), 1 sub-subtype A6 (0.5%), 1 sub-subtype F1 (0.5%) and 1 U (0.5%). Among the 34 (26.6%) of 128 U LANL sequences from the DRC, 12 turned out to be subtype A (35.3%), 4 sub-subtype F1 (11.8%), 3 sub-subtype A4 (8.8%), 3 sub-subtype A5 (8.8%), 3 subtype D (8.8%), 3 CRF18_cpx (8.8%), 2 subtype K (5.9%), 1 CRF02_AG (2.9%), 1 subtype G (2.9%), 1 subtype H (2.9%), and 1 (0.5%) subtype L. Thus, one third (32.9%) of sub-subtype A1 and a quarter (26.6%) of U LANL sequences from the DRC had been previously misclassified.<fig id="Fig3"><label>Figure 3</label><caption><p>Comparison of HIV-1 variants in the study cohort (2016&#x02013;2018) versus LANL sequences from the DRC (1976&#x02013;2012) and Kinshasa (1983&#x02013;2008). (<bold>A</bold>) Comparison of HIV-1 variants in the study cohort from Kinshasa (2016&#x02013;2018) versus DRC sequences available in LANL (1976&#x02013;2012). (<bold>B</bold>) Comparison of data between study cohort and LANL. (<bold>C</bold>) Evolution of pure subtypes and recombinants forms in the DRC by periods of time during 1983&#x02013;2018. Panel C excludes <italic>pol</italic> sequences from the DRC sampled during 1977&#x02013;1982, 1986, 1995, 2009, 2010, 2013&#x02013;2015, due to their absence in LANL database. We clustered all sequences sampled during 1983&#x02013;1994 as an &#x0201c;early period&#x0201d; to avoid biases due to the non-representative number of <italic>pol</italic> sequences each year within that period. Panels B and C exclude 214 LANL sequences from the DRC with unknown sampling time collected before 2012. (<bold>D</bold>) Comparison of HIV-1 variants distribution circulating in Kinshasa during 1983&#x02013;2008 versus 2016&#x02013;2018. For analysis we used the 181 <italic>pol</italic> sequences with available GenBank accession number from samples collected in that city during 1983&#x02013;2008 versus the new 165 <italic>pol</italic> sequences collected during 2016&#x02013;2018 reported in this study. Cpx, complex; CRF, circulating recombinant form; URF, unique recombinant form. *<italic>p</italic> value&#x02009;&#x0003c;&#x02009;0.05.</p></caption><graphic xlink:href="41598_2020_74558_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec7"><title>Changes in the HIV-1 molecular epidemiology in the DRC (1976&#x02013;2018) and in Kinshasa (1983&#x02013;2018)</title><p id="Par13">In order to analyze the HIV-1 molecular epidemiology evolution over time in the DRC, we compared the current HIV-1 variants in <italic>pol</italic> circulating in Kinshasa (2016&#x02013;2018) with the 2588 <italic>pol</italic> sequences previously reported in the country with known sampling year (1976&#x02013;2012) and newly reclassified in this study. Globally, a significant reduction (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) in the percentage of pure subtypes and simultaneously an increase of URFs (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), were observed after comparing both periods, whereas the proportion of CRFs remained similar across both sequence sets (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A,&#x000a0;B). The evolution of pure subtypes and recombinant forms in the DRC across a three-year period until 2018 is shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C.</p><p id="Par14">HIV-1 variant distribution varies greatly between provinces and it is not possible to compare the diversity in Kinshasa with that of the whole country. We therefore performed a new analysis using all available <italic>pol</italic> sequences deposited in LANL recovered from samples collected in Kinshasa after identifying the accession numbers in the corresponding papers, recovering 181 <italic>pol</italic> sequences from different subjects. We then compared the HIV-1 variant distribution in Kinshasa from the 181 samples collected exclusively in the city during 1983&#x02013;2008 (94.5% of them sampled during 2007&#x02013;2008) versus the new 165 <italic>pol</italic> sequences collected during 2016&#x02013;2018 in Kinshasa and newly reported in this study. We observed during 2016&#x02013;2018 a significant increase in subtype A (10.5% vs. 26.7%, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and sub-subtype F1 (0% vs. 4.8%, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and a significant reduction in sub-subtype A1 (11% vs. 0%, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and subtype D (7.7% vs. 2.4%, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) compared to variants from Kinshasa circulating from 1983 to 2008, whereas the proportion of CRFs remained similar across both sequence sets (12.1 vs. 13.2%, respectively). We detected CRF47_BF virus for the first time in the country using <italic>po</italic>l sequences collected after 2016. URF tended to decrease over time (31% vs. 23.6%). The remaining variants remained stable over time (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>D).</p></sec><sec id="Sec8"><title>Differences on genetic diversity across <italic>pol</italic> sequences sets from the DRC</title><p id="Par15">The global genetic diversity across the 2802 LANL <italic>pol</italic> sequences (1976&#x02013;2012) versus our 165 <italic>pol</italic> sequence set under study (2016&#x02013;2018) reported similar values (0.90 vs. 0.91) (Table <xref rid="Tab4" ref-type="table">4</xref>). However, considering specific HIV-1 variants, LANL set presented higher genetic diversity in pure-subtypes (0.84 vs. 0.76), whereas diversity of CRFs was higher since 2016 (0.78 vs. 0.89). When the genetic diversity was compared into the most recent sequences, according to age group, it was higher in children/adolescents than adults (0.92 vs. 0.88), mainly in URF variants (0.93 vs. 0.80), whereas in CRFs the diversity was higher in adults versus children/adolescents (0.88 vs. 0.50) (Table <xref rid="Tab4" ref-type="table">4</xref>). Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>, shows the high genetic diversity over time in <italic>pol</italic> sequences sampled in the DRC since the 1976 (year of first available <italic>pol</italic> sequence) to 2018, with some variations by periods of time.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Genetic diversity by study groups in HIV-1 <italic>pol</italic> sequences from the DRC.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">LANL DRC <break/>1976&#x02013;2012</th><th align="left" colspan="3">Study cohort Kinshasa 2016-2018</th></tr><tr><th align="left">Total</th><th align="left">Children/adolescents</th><th align="left">Adults</th></tr></thead><tbody><tr><td align="left">Total</td><td align="left"><p>0.90</p><p>(n&#x000a0;=&#x000a0;2802)</p></td><td align="left"><p>0.91</p><p>(n&#x000a0;=&#x000a0;165)</p></td><td align="left"><p>0.92</p><p>(n&#x000a0;=&#x000a0;55)</p></td><td align="left"><p>0.88</p><p>(n&#x000a0;=&#x000a0;110)</p></td></tr><tr><td align="left">Pure subtypes</td><td align="left"><p>0.84</p><p>(n&#x000a0;=&#x000a0;2198)</p></td><td align="left"><p>0.76</p><p>(n&#x000a0;=&#x000a0;99)</p></td><td align="left"><p>0.73</p><p>(n&#x000a0;=&#x000a0;29)</p></td><td align="left"><p>0.75</p><p>(n&#x000a0;=&#x000a0;70)</p></td></tr><tr><td align="left">CRF</td><td align="left"><p>0.78</p><p>(n&#x000a0;=&#x000a0;333)</p></td><td align="left"><p>0.89</p><p>(n&#x000a0;=&#x000a0;21)</p></td><td align="left"><p>0.50</p><p>(n&#x000a0;=&#x000a0;2)</p></td><td align="left"><p>0.88</p><p>(n&#x000a0;=&#x000a0;19)</p></td></tr><tr><td align="left">URF</td><td align="left"><p>0.95</p><p>(n&#x000a0;=&#x000a0;176)</p></td><td align="left"><p>0.92</p><p>(n&#x000a0;=&#x000a0;39)</p></td><td align="left"><p>0.93</p><p>(n&#x000a0;=&#x000a0;22)</p></td><td align="left"><p>0.80</p><p>(n&#x000a0;=&#x000a0;17)</p></td></tr></tbody></table><table-wrap-foot><p>CRF, circulating recombinant form; URF, unique recombinant form; n, number of <italic>pol </italic>sequences; LANL, Los Alamos HIV Sequence database.</p></table-wrap-foot></table-wrap><fig id="Fig4"><label>Figure 4</label><caption><p>Temporal trends of genetic diversity across years in HIV-1 <italic>pol</italic> sequences from the DRC. Bars in blue, available <italic>pol</italic> sequences from the DRC with known sampling year. LANL database did not include <italic>pol</italic> sequences from the DRC sampled during 1977&#x02013;1982, 1986, 1995, 2009, 2010, and 2013&#x02013;2015.</p></caption><graphic xlink:href="41598_2020_74558_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec9"><title>Discussion</title><p id="Par16">The DRC is known as the origin of HIV-1 pandemic and the epicenter for the selection and spreading of many HIV-1 variants to neighboring countries<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. As a consequence of high HIV-1 genetic heterogenicity (probably the highest diversity rate in the world), the accurate phylogenetic reconstructions have not been easy to interpret<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. For this reason, our first approach was to reanalyze the available HIV-1 sequences deposited in LAN from the DRC, observing 8.8% of misclassified sequences according to the new reclassification of HIV-1 variants and phylogenetic programs used in this work.</p><p id="Par17">Global geographical patterns in HIV-1 variants distribution are changing over time due to several factors, such as population movements or the dense transmission networks. These factors are contributing to an unpredictable HIV-1 pandemic<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. Consequently, a continuous and accurate molecular epidemiology surveillance is necessary for increasing our knowledge about the evolving HIV-1 epidemic, especially in those geographical areas with high genetic diversity rate, where multiple HIV-1 variants co-circulate<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>, such as the DRC. In these settings, the selection of new recombinant forms is easier and the viral evolution could be faster than in those regions with low diversity of HIV-1<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.</p><p id="Par18">Due to the lack of updated data on HIV molecular epidemiology in the DRC, we present the information of 165 <italic>pol</italic> sequences obtained in adult and paediatric populations, representing the most recent data on circulating HIV-1 subtypes and recombinant forms in Kinshasa ranging 2016&#x02013;2018. We also compared the temporal trends of HIV-1 variants in the DRC for a 43-years period, based on 28<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR34">34</xref>&#x02013;<xref ref-type="bibr" rid="CR56">56</xref></sup> published studies. Sup. Table <xref rid="MOESM1" ref-type="media">1</xref> shows the sampling year, sample type, study population, number of analyzed sequences, coding regions, subtyping method and sequence submission to databases in each 28 published studies characterizing HIV-1 variants in the DRC. Since HIV is prone to recombination during retrotranscription, high levels of recombinant forms after coinfections or superinfections are expected, especially in places with high viral diversity, such as in the DRC<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. In this scenario HIV-1 can accelerate adaptation to the host, favouring emerging variants with unknown pathogenicity<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p><p id="Par19">Previous studies have also reported heterogeneous geographic distribution of group M variants across regions in the DRC<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>, with high prevalence of recombinants. However, HIV recombinant rates in our study and previously reported in the country could be underestimated since most of them were classified by using short partial genome sequences (Sup. Table <xref rid="MOESM1" ref-type="media">1</xref>) and not full genomes. Thus, the recombinant rate in the DRC could be even higher if more viral regions are assessed. Although the biological and clinical impact remains to be clarified, there is growing evidence that&#x000a0;recombination&#x000a0;has played a significant role in the early history of the&#x000a0;HIV-1 pandemic and in viral evolution<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. We reported the first identification of CRF47_BF in Africa and the DRC, a recombinant variant first described in Spain<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. It would also suggest a possible importation of subtype B to the DRC.</p><p id="Par20">This study confirmed subtype A as the most prevalent subtype, which has maintained a high rate of infections in the DRC over the last three decades<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>, explaining the high rate of URF carrying subtype A fragments circulating in Kinshasa described in the last years. Kinshasa has been proposed as the origin of A, G and F1 subtypes<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>, common found HIV-1 variants in our series. Although subtype D was associated with faster disease progression<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>, was also initially emerged in Kinshasa, its prevalence decreased in the city during 2016&#x02013;2018 compared to previous years. Although a significant increase of subtype C was reported from 1997 to 2002 in Kinshasa<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, in other countries close to the DRC<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> and worldwide<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, we observed a similar prevalence of this variant in Kinshasa comparing the two time periods under study. The reasons for these findings are unknown.</p><p id="Par21">We also found that almost 4 out of 10 variants circulating in Kinshasa during both periods (1983&#x02013;2008 and 2016&#x02013;2018) carried recombinant sequences in <italic>pol</italic>. When CRFs and URFs diversities were analysed according to age of patients, CRFs diversity in <italic>pol</italic> was higher in adults and URF diversity higher in children/adolescents in the last period. The trends of HIV-1 genetic diversity should be further explored in the coming years, also including other HIV-1 genes. The high misclassification in sub-subtype A and U <italic>pol</italic> sequences from the DRC deposited in LANL reveals the need for reclassification by phylogeny with updated reference sequence sets and new reported HIV-1 variants.</p><p id="Par22">Phylogenetic approaches and distance-based analysis represent the most common strategy to identify recent transmission networks<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, and it could be useful to identify other HIV infected and uninfected persons at highest risk of transmission who could benefit from HIV prevention interventions<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Some reports have demonstrated that genetic distance restrictive thresholds between 0.01 and 0.02 substitutions per site have been more strongly associated with probable transmission partners than traditional epidemiological connections<sup><xref ref-type="bibr" rid="CR65">65</xref>&#x02013;<xref ref-type="bibr" rid="CR67">67</xref></sup>, and a distance of 0.015 could serve as a use proxy for epidemiological relatedness in a surveillance setting<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. Our study identified that 3 out of 4 transmission clusters were recent (genetic distance thresholds 0.01&#x02013;0.02<sup><xref ref-type="bibr" rid="CR65">65</xref>&#x02013;<xref ref-type="bibr" rid="CR67">67</xref></sup>). We implemented a strategy based on traceability of genetic fragments, to know the potential network among infected people (Sup. Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6</xref>). This strategy, &#x0201c;recombination network&#x0201d;, gave us a dense net and probably a more complete view. The recombination network found involving <italic>pol</italic> sequences from 17 children/adolescents with no epidemiological link according to clinical data confirmed the important role of recombination in an HIV pandemic and the importance of common ancestor identification to understand recombination origin and spread. As the children are overrepresented in this network, we should suspect that this network is even denser.</p><p id="Par23">This study has some limitations that need to be considered. Firstly, samples from 2016&#x02013;2018 were collected in two reference hospitals in Kinshasa, which cannot be fully representative of the situation in a city and even more at a country-wide level<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. However, the inclusion of all <italic>pol</italic> sequences from LANL collected in the country over more than 4 decades, from the general population and risk groups, provides a good overview of the huge diversity of the country. A second limitation is the length of recovered <italic>pol</italic> sequences, which differed across samples, complicating bioinformatic analysis. A third limitation is that some reports in the DRC did not submit sequences to databases, and they were not available in LANL (Sup. Table <xref rid="MOESM1" ref-type="media">1</xref>). These reported HIV-1 variants could therefore not be reevaluated by new PhyML analysis to be included in the temporal tend analysis of HIV-1 variants. Thus, we encourage the necessity of sequence submission in all HIV epidemiology studies worldwide before publication, and the inclusion of the sampling year in all submitted sequences, absent in 214 (8%) of <italic>pol</italic> sequences downloaded from LANL in that country. The lack of routine resistance testing during clinical follow-up of HIV-infected subjects in the DRC limits the <italic>pol</italic> sequences availability in the DRC. Furthermore, the lack of complete epidemiological information from subjects involved in transmission or recombination clusters limits full understanding of a cluster&#x000b4;s origin. Finally, 51.5% of DBS did not yield any viral sequences, possibly due to the low viral load (40&#x02013;1000 HIV-1 RNA copies/dot) in more than half of specimens and to the low plasma volume in the 2 dots used for HIV-1 RNA extraction, limiting the ability to get positive PCR amplifications of HIV in these samples.</p><p id="Par24">Since none of sequences downloaded form LANL was sampled after 2012, our sequence set was the most recent in the DRC to date and the highest in number of analyzed <italic>pol</italic> sequences in Kinshasa. Our study reinforces the use of dried blood as a field-friendly, useful, convenient and alternative specimen type to whole blood or plasma in HIV molecular epidemiology surveillance studies in developing countries or settings with limitations as regards the collection, storing, transportation of plasma or when low blood volume is available<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. Only 3 of 27 studies reporting variants in the DRC<sup><xref ref-type="bibr" rid="CR48">48</xref>,<xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup> had used DBS for HIV-1 variant characterization (Sup. Table <xref rid="MOESM1" ref-type="media">1</xref>). Although two previous studies reported the full HIV-1 genome (including <italic>pol</italic>) from a vertically infected 12-month-old baby<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> or <italic>gag</italic> sequences from 15 children in Kimpese, rural DRC<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>, our study presents the most extensive data regarding HIV-infected children and adolescents in the country. The updated high genetic diversity observed in the DRC also represents a real challenge for future vaccine development and for efficiency of antiretroviral treatment, diagnostic and monitoring tests of HIV infection<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>.</p><p id="Par25">In conclusion, we report the most recent data related to HIV-1 variants circulating in Kinshasa, the geographical origin of the pandemic, and unique and updated information on the temporal trends of HIV-1 subtypes, CRF and URF in the DRC during 43-year period (from 1976 to 2018) and in Kinshasa from 1983&#x02013;2018 after reclassification of several available LANL sequences using phylogenetic approach. The data provided increase and update the knowledge of HIV molecular epidemiology in the DRC. Active transmission clusters were detected, and a new strategy offers us a more complete view of transmission networks. Of concern is an overrepresentation of children was observed in the recombination network. Continued molecular surveillance will be essential to determine and trace rare unique recombinant forms or emerging strains of HIV in the country.</p></sec><sec id="Sec10"><title>Material and methods</title><sec id="Sec11"><title>Sample collection and viral load quantification</title><p id="Par26">From 2016 to 2018, 2 DBS cards were collected from 340 patients under clinical follow up at Monkole and Kalembelembe Hospitals (Kinshasa, DRC), 71 HIV-infected children (0&#x02013;14&#x000a0;years) and adolescents (15&#x02013;21&#x000a0;years) and 269 HIV-infected adults (more than 22&#x000a0;years). DBS preparation and viral load quantification was performed using Cobas Ampliprep/Cobas Taqman HIV-1 test v2.0 (Roche) as previously reported<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> considering hematocrit<sup><xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR71">71</xref></sup>.</p></sec><sec id="Sec12"><title>Amplification and sequencing</title><p id="Par27">For HIV-1 variant characterization, viral RNA was extracted from 2 DBS dots using NucliSENS EeasyMAG automated platform (BioMerieux) or manual High-Pure Viral Nucleic Acid kit (Roche). The encoding regions PR, RT, and/or IN at HIV-1 <italic>pol</italic> gene&#x000a0;were amplified by RT-PCR and nested-PCR using primers designed by WHO<sup><xref ref-type="bibr" rid="CR72">72</xref></sup> and ANRS<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. PCR amplicons were purified using the Illustra ExoProStar 1-Step (GE Healthcare Life Sciences, Little Chalfont, UK) and sequenced by Macrogen Inc. (Geumchun-gu, Seoul, Korea). Viral sequences included the complete HIV-1 PR (codons 1&#x02013;99), partial RT (codons 1&#x02013;335/440) and IN (codons 1&#x02013;285).</p></sec><sec id="Sec13"><title>Accession numbers</title><p id="Par28">PR, RT and IN HIV-1 sequences were submitted to GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/genbank">www.ncbi.nlm.nih.gov/genbank</ext-link>) with the following accession numbers: MH920378-MH920435, MN530990-MN531082, MN998509-MN998523.</p></sec><sec id="Sec14"><title>Phylogenetic analysis</title><p id="Par29">Nucleotide sequences were translated and aligned using the ClustalW algorithm implemented in MEGA6. For HIV-1 subtype characterization we used sequences available in Los Alamos HIV Sequence Database (LANL: <ext-link ext-link-type="uri" xlink:href="https://www.hiv.lanl.gov">https://www.hiv.lanl.gov</ext-link>), annotated by country of origin and date. Reference sequences from all HIV-1 variants described to date with available sequence were included (groups, subtypes, sub-subtypes, CRFs). One HIV-1 group N sequence was used as an outgroup. Sequences from groups P/O/N were also downloaded to discard non group-M infections. To alleviate the burden of computer-time required to reconstruct large phylogenies fast algorithms, phylogenetic trees (PhyMLtree) were reconstructed by maximum-likelihood (ML) method with RAxML v8.0 (Randomized Axelerated Maximum Likelihood)<sup><xref ref-type="bibr" rid="CR74">74</xref></sup> using the general time reversible plus proportion of invariable sites plus gamma distribution parameter (GTR&#x02009;+&#x02009;I&#x02009;+&#x02009;G) evolutionary model. To estimate the bootstrap values on the inferred topology by RAxML, Shimodaira-Hasegawa (SH) test using FastTree program was used (support&#x02009;&#x0003e;&#x02009;90%)<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. Sequences not clustering with any variant were analyzed using Recombination Detection Program (RDP3v4.13)<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>, identifying the subtypes involved in eventual recombination events and hypothetical recombination breakpoints. To further confirm the detected putative recombination events, new phylogenetic analyses were performed using the sequence fragments assigned to different subtypes according to the proposed breakpoint position(s) defined by RPD3. The topologies obtained with each fragment were compared to SH, expected likelihood weight, and Kishino-Hasegawa tests using the TREE-PUZZLE 5.2 program. In the positive cases, the recombinant sequences were redefined as URFs; otherwise, sequences with a most recent common ancestor to subtypes sub-subtypes A1-A6 or F1-F2 were identified as subtypes A or F, respectively. The remaining cases were appointed as U. Since it was not possible to sequence the same fragment for all sequences, different regions were analyzed separately.</p><p id="Par30">Transmission clusters in our 165 study sequences from Kinshasa (2006&#x02013;2018) were defined as viral sequences belonging to the same subtype/CRF/URF and grouped into a single and well-supported cluster (monophyletic clade) with 100% bootstrap values. When only partial <italic>pol</italic> sequences could be recovered from new samples, each available sequence fragment present in all viruses from the cluster was used for analysis separately. In this way, new recombination events were detected. Sequences with different recombination events but sharing some recombinant fragment and common progenitor virus were considered as transmission networks.</p><p id="Par31">Genetic diversity (<italic>D</italic>&#x02009;=&#x02009;1&#x02009;&#x02212;&#x02009;&#x02211;<italic>f</italic><sup>2</sup>) of HIV variants in the DRC was analyzed over time, a measure of variability that takes into account the frequencies (<italic>f</italic>) of all variants. For that purpose, all 2802 <italic>pol</italic> LANL sequences from the DRC were downloaded and reclassified as previously described. Among them, 2588 (92.3%) reported the sampling year, all belonging to the 1976&#x02013;2012 period. Viral genetic diversity among HIV-infected children and adults with samples collected in Kinshasa between 2016 and 2018 was also calculated. We analyzed the genetic distance (number of base substitutions per site) or the average evolutionary divergence over all sequence pairs by using the Tamura-Nei model 93 (TN93)<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>, according to previous reports<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. The rate variation among sites was modeled with a <italic>gamma</italic> distribution and analysis was conducted in MEGA6. We identified a recent transmission cluster in <italic>pol</italic> sequences showing maximum pairwise genetic distance lower than 0.01, according to previous reports<sup><xref ref-type="bibr" rid="CR65">65</xref>&#x02013;<xref ref-type="bibr" rid="CR67">67</xref></sup>. TN93 was used because it is the most general nucleotide substitution model for which distances can be estimated directly from counts of nucleotide pairs in aligned sequences.</p></sec><sec id="Sec15"><title>Ethical aspects</title><p id="Par32">The project was approved by the Human Subjects Review Committees at Monkole Hospital/University of Kinshasa (Kinshasa, DRC), University Hospital Ram&#x000f3;n y Cajal (Madrid, Spain) and University of Navarra (Pamplona, Spain). Informed consent of all enrolled adults and of parents or guardians of enrolled children was obtained. All methods were carried out in accordance with relevant guidelines and regulations. Patients&#x02019; names were codified at sampling to maintain confidentiality.</p></sec><sec id="Sec16"><title>Statistical analysis</title><p id="Par33">Differences in prevalence of HIV-1 variants were tested using T-test and <italic>p values</italic>&#x02009;&#x0003c;&#x02009;0.05 were considered statistically significant. Descriptive statistical analysis was performed, median and interquartile range (IQR) was also calculated. Statistical analyses were conducted using Prism 6.0 software from GraphPad version 8.0.1 (San Diego, CA, USA).</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec17"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2020_74558_MOESM1_ESM.pdf"><caption><p>Supplementary Information.</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Marina Rubio-Garrido and Jos&#x000e9; Mar&#x000ed;a Gonz&#x000e1;lez-Alba.</p></fn></fn-group><sec><title>Supplementary information</title><p> is available for this paper at 10.1038/s41598-020-74558-z.</p></sec><ack><title>Acknowledgements</title><p>We thank the patients who participated in the study as well as the local professionals responsible for the DBS and data collection of enrolled patients at Monkole and Kalembelembe hospitals in Kinshasa. We also thank Paul Devlin for his proofreading of the manuscript.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>A.H. and G.R. conceived and designed the study. M.R.G, J.M.G, AH, and J.C.G contributed to data analysis and result discussion. A.H. and S.C. organized in sample shipping. A.N. selected clinical and epidemiological data from patients in DRC and supervised DBS collection and shipping. M.R.G performed the virological analysis of adolescents and paediatric samples and viral sequencing, D.B performed viral amplification and sequencing of adults samples. M.R.G and J.M.G carried out the phylogenetic analysis for variant characterization of the complete study cohort. A.H. and J.C.G supervised phylogenetic analysis. D.B and G.R. performed sequencing and HIV-1 viraemia quantification by Roche assay. A.H, and M.R.G designed final tables and figures and wrote the manuscript. A.N, J.C.G, G.R and S.C revised the paper. All authors approved the final version of manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was funded by fundraising&#x000a0;activities&#x000a0;and donations (mainly of Asociaci&#x000f3;n&#x000a0;Bomberos Ayudan), by Instituto de Salud Carlos III through the Projects PI16/01908 and PI18/00904" (Plan Estatal de Investigaci&#x000f3;n Cient&#x000ed;fica y T&#x000e9;cnica y de Innovaci&#x000f3;n 2013&#x02013;2016 and cofinanced by the European Development Regional Fund &#x0201c;A way to achieve Europe&#x0201d;-FEDER and the Government of Navarre (Grant 045-2015). The study was integrated in the research supported by the Spanish HIV infected Paediatric Cohort (CoRISpe) integrated in the Spanish AIDS Research Network and by Instituto de Salud Carlos III, Spanish Health Ministry (Grant n&#x000ba; RD06/0025-ISCIII-FEDER). This study is also included in the &#x0201c;Subprograma de Inmigraci&#x000f3;n y Salud&#x0201d; from CIBERESP (Spain).</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par34">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worobey</surname><given-names>M</given-names></name><etal/></person-group><article-title>Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960</article-title><source>Nature</source><year>2008</year><volume>455</volume><fpage>661</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1038/nature07390</pub-id><?supplied-pmid 18833279?><pub-id pub-id-type="pmid">18833279</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">UNAIDS. AIDSinfo. <ext-link ext-link-type="uri" xlink:href="https://aidsinfo.unaids.org/">https://aidsinfo.unaids.org/</ext-link>.</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr&#x000e9;-Sinoussi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)</article-title><source>Rev. Investig. Clin.</source><year>2004</year><volume>56</volume><fpage>126</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">15378805</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F</given-names></name><etal/></person-group><article-title>Human infection by genetically diverse SIVSM-related HIV-2 in West Africa</article-title><source>Nature</source><year>1992</year><volume>358</volume><fpage>495</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1038/358495a0</pub-id><?supplied-pmid 1641038?><pub-id pub-id-type="pmid">1641038</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F</given-names></name><etal/></person-group><article-title>Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes</article-title><source>Nature</source><year>1999</year><volume>397</volume><fpage>436</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1038/17130</pub-id><?supplied-pmid 9989410?><pub-id pub-id-type="pmid">9989410</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>JHM</given-names></name><name><surname>Gaddis</surname><given-names>NC</given-names></name><name><surname>Fouchier</surname><given-names>RAM</given-names></name><name><surname>Malim</surname><given-names>MH</given-names></name></person-group><article-title>Evidence for a newly discovered cellular anti-HIV-1 phenotype</article-title><source>Nat. Med.</source><year>1998</year><volume>4</volume><fpage>1397</fpage><lpage>1400</lpage><pub-id pub-id-type="doi">10.1038/3987</pub-id><?supplied-pmid 9846577?><pub-id pub-id-type="pmid">9846577</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plantier</surname><given-names>JC</given-names></name><etal/></person-group><article-title>A new human immunodeficiency virus derived from gorillas</article-title><source>Nat. Med.</source><year>2009</year><volume>15</volume><fpage>871</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1038/nm.2016</pub-id><?supplied-pmid 19648927?><pub-id pub-id-type="pmid">19648927</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Leys</surname><given-names>R</given-names></name><etal/></person-group><article-title>Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin</article-title><source>J. Virol.</source><year>1990</year><volume>64</volume><fpage>1207</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1128/JVI.64.3.1207-1216.1990</pub-id><?supplied-pmid 2304140?><pub-id pub-id-type="pmid">2304140</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>DL</given-names></name></person-group><article-title>HIV-1 nomenclature proposal</article-title><source>Science</source><year>2000</year><volume>288</volume><issue>5463</issue><fpage>55</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1126/science.288.5463.55d</pub-id><?supplied-pmid 10766634?><pub-id pub-id-type="pmid">10766634</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>J</given-names></name><etal/></person-group><article-title>Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2020</year><volume>83</volume><issue>3</issue><fpage>319</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000002246</pub-id><?supplied-pmid 31693506?><pub-id pub-id-type="pmid">31693506</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Los Alamos HIV Sequence Database. HIV Circulating Recombinant Forms (CRFs). <ext-link ext-link-type="uri" xlink:href="https://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html#CRF01">https://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html#CRF01</ext-link>.</mixed-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>NR</given-names></name><etal/></person-group><article-title>The early spread and epidemic ignition of HIV-1 in human populations</article-title><source>Science</source><year>2014</year><volume>346</volume><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1126/science.1256739</pub-id><?supplied-pmid 25278604?><pub-id pub-id-type="pmid">25278604</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baeten</surname><given-names>JM</given-names></name><etal/></person-group><article-title>HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads</article-title><source>J. Infect. Dis.</source><year>2007</year><volume>195</volume><fpage>1177</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1086/512682</pub-id><?supplied-pmid 17357054?><pub-id pub-id-type="pmid">17357054</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amornkul</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa</article-title><source>AIDS</source><year>2013</year><volume>27</volume><fpage>2775</fpage><lpage>2786</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000000012</pub-id><?supplied-pmid 24113395?><pub-id pub-id-type="pmid">24113395</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venner</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Infecting HIV-1 subtype predicts disease progression in women of sub-Saharan Africa</article-title><source>EBioMedicine</source><year>2016</year><volume>13</volume><fpage>305</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2016.10.014</pub-id><?supplied-pmid 27751765?><pub-id pub-id-type="pmid">27751765</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Control of the HIV-1 load varies by viral subtype in a large cohort of African adults with incident HIV-1 infection</article-title><source>J. Infect. Dis.</source><year>2019</year><volume>220</volume><fpage>432</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiz127</pub-id><?supplied-pmid 30938435?><pub-id pub-id-type="pmid">30938435</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>P</given-names></name><etal/></person-group><article-title>HIV-1 variability and viral load technique could lead to false positive HIV-1 detection and to erroneous viral quantification in infected specimens</article-title><source>J. Infect.</source><year>2015</year><volume>71</volume><fpage>368</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2015.05.011</pub-id><?supplied-pmid 26033694?><pub-id pub-id-type="pmid">26033694</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhargava</surname><given-names>M</given-names></name><name><surname>Cajas</surname><given-names>JM</given-names></name><name><surname>Wainberg</surname><given-names>MA</given-names></name><name><surname>Klein</surname><given-names>MB</given-names></name><name><surname>Pai</surname><given-names>NP</given-names></name></person-group><article-title>Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review</article-title><source>J. Int. AIDS Soc.</source><year>2014</year><volume>17</volume><fpage>18944</fpage><pub-id pub-id-type="doi">10.7448/IAS.17.1.18944</pub-id><?supplied-pmid 24998532?><pub-id pub-id-type="pmid">24998532</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacktor</surname><given-names>N</given-names></name><etal/></person-group><article-title>HIV Subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda</article-title><source>Clin. Infect. Dis.</source><year>2009</year><volume>49</volume><fpage>780</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1086/605284</pub-id><?supplied-pmid 19622045?><pub-id pub-id-type="pmid">19622045</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>JK</given-names></name></person-group><article-title>Viral diversity as a challenge to HIV-1 vaccine development</article-title><source>Curr. Opin. HIV AIDS</source><year>2006</year><volume>1</volume><fpage>294</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1097/01.COH.0000232344.23533.be</pub-id><?supplied-pmid 19372824?><pub-id pub-id-type="pmid">19372824</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>BS</given-names></name><name><surname>Sobieszczyk</surname><given-names>ME</given-names></name><name><surname>McCutchan</surname><given-names>FE</given-names></name><name><surname>Hammer</surname><given-names>SM</given-names></name></person-group><article-title>The challenge of HIV-1 subtype diversity</article-title><source>N. Engl. J. Med.</source><year>2008</year><volume>358</volume><fpage>1590</fpage><pub-id pub-id-type="doi">10.1056/NEJMra0706737</pub-id><?supplied-pmid 18403767?><pub-id pub-id-type="pmid">18403767</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tebit</surname><given-names>DM</given-names></name><name><surname>Arts</surname><given-names>EJ</given-names></name></person-group><article-title>Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease</article-title><source>Lancet. Infect. Dis.</source><year>2011</year><volume>11</volume><fpage>45</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(10)70186-9</pub-id><?supplied-pmid 21126914?><pub-id pub-id-type="pmid">21126914</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junqueira</surname><given-names>DM</given-names></name><name><surname>de Matos Almeida</surname><given-names>SE</given-names></name></person-group><article-title>HIV-1 subtype B: Traces of a pandemic</article-title><source>Virology</source><year>2016</year><volume>495</volume><fpage>173</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2016.05.003</pub-id><?supplied-pmid 27228177?><pub-id pub-id-type="pmid">27228177</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>N</given-names></name><etal/></person-group><article-title>Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) Group M genetic diversity in the democratic republic of congo suggests that the HIV-1 pandemic originated in central Africa</article-title><source>J. Virol.</source><year>2000</year><volume>74</volume><fpage>10498</fpage><lpage>10507</lpage><pub-id pub-id-type="doi">10.1128/JVI.74.22.10498-10507.2000</pub-id><?supplied-pmid 11044094?><pub-id pub-id-type="pmid">11044094</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pineda-Pe&#x000f1;a</surname><given-names>AC</given-names></name><etal/></person-group><article-title>On the contribution of Angola to the initial spread of HIV-1</article-title><source>Infect. Genet. Evol.</source><year>2016</year><volume>46</volume><fpage>219</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2016.08.009</pub-id><?supplied-pmid 27521160?><pub-id pub-id-type="pmid">27521160</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>T</given-names></name><etal/></person-group><article-title>An African HIV-1 sequence from 1959 and implications for the origin of the epidemic</article-title><source>Nature</source><year>1998</year><volume>391</volume><fpage>594</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1038/35400</pub-id><?supplied-pmid 9468138?><pub-id pub-id-type="pmid">9468138</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gryseels</surname><given-names>S</given-names></name><etal/></person-group><article-title>A near-full-length HIV-1 genome from 1966 recovered from formalin-fixed paraffin-embedded tissue</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2020</year><volume>117</volume><fpage>12222</fpage><lpage>12229</lpage><pub-id pub-id-type="doi">10.1073/pnas.1913682117</pub-id><?supplied-pmid 32430331?><pub-id pub-id-type="pmid">32430331</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa</article-title><source>PLoS Pathog.</source><year>2019</year><volume>15</volume><fpage>e1007976</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1007976</pub-id><?supplied-pmid 31809523?><pub-id pub-id-type="pmid">31809523</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Sensitive next-generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo</article-title><source>J. Virol.</source><year>2017</year><volume>91</volume><issue>6</issue><fpage>e01841&#x02013;16</fpage><pub-id pub-id-type="doi">10.1128/JVI.01841-16</pub-id><?supplied-pmid 28077647?><pub-id pub-id-type="pmid">28077647</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamangu</surname><given-names>EN</given-names></name></person-group><article-title>Implication of neighbors in the genetic diversity of the human immunodeficiency virus type 1 in the Democratic Republic of Congo</article-title><source>ARC J. AIDS</source><year>2018</year><volume>3</volume><fpage>26</fpage><lpage>28</lpage></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeters</surname><given-names>M</given-names></name><name><surname>Mulanga-Kabeya</surname><given-names>C</given-names></name><name><surname>Delaporte</surname><given-names>E</given-names></name></person-group><article-title>The genetic diversity of HIV-1</article-title><source>Virologie</source><year>2020</year><volume>4</volume><issue>5</issue><fpage>313</fpage><lpage>320</lpage></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaschen</surname><given-names>B</given-names></name><etal/></person-group><article-title>Diversity considerations in HIV-1 vaccine selection</article-title><source>Science (80-)</source><year>2002</year><volume>296</volume><fpage>2354</fpage><lpage>2360</lpage><pub-id pub-id-type="doi">10.1126/science.1070441</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemelaar</surname><given-names>J</given-names></name><etal/></person-group><article-title>Global and regional molecular epidemiology of HIV-1, 1990&#x02013;2015: a systematic review, global survey, and trend analysis</article-title><source>Lancet Infect. Dis.</source><year>2019</year><volume>19</volume><fpage>143</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(18)30647-9</pub-id><?supplied-pmid 30509777?><pub-id pub-id-type="pmid">30509777</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Genetic diversification and recombination of HIV type 1 group M in Kinshasa, Democratic Republic of Congo</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2005</year><volume>21</volume><fpage>661</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1089/aid.2005.21.661</pub-id><?supplied-pmid 16060838?><pub-id pub-id-type="pmid">16060838</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2001</year><volume>17</volume><fpage>361</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1089/08892220150503726</pub-id><?supplied-pmid 11242522?><pub-id pub-id-type="pmid">11242522</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Trask</surname><given-names>SA</given-names></name><name><surname>Hui</surname><given-names>H</given-names></name><name><surname>Mamaeva</surname><given-names>O</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Theodore</surname><given-names>TS</given-names></name><name><surname>Foley</surname><given-names>BT</given-names></name><name><surname>Korber</surname><given-names>BT</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Beatrice</surname><given-names>HH</given-names></name></person-group><article-title>Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2001</year><volume>17</volume><issue>12</issue><fpage>1217</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1089/088922201316912826</pub-id><?supplied-pmid 11522191?><pub-id pub-id-type="pmid">11522191</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kita</surname><given-names>K</given-names></name><etal/></person-group><article-title>Genetic diversity of HIV type 1 in Likasi, southeast of the Democratic Republic of Congo</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2004</year><volume>20</volume><fpage>1352</fpage><lpage>1357</lpage><pub-id pub-id-type="doi">10.1089/aid.2004.20.1352</pub-id><?supplied-pmid 15650428?><pub-id pub-id-type="pmid">15650428</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>N</given-names></name><etal/></person-group><article-title>Distribution of HIV-1 variants in the Democratic Republic of Congo suggests increase of subtype C in Kinshasa between 1997 and 2002</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2005</year><volume>40</volume><fpage>456</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1097/01.qai.0000159670.18326.94</pub-id><?supplied-pmid 16280702?><pub-id pub-id-type="pmid">16280702</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>N</given-names></name><etal/></person-group><article-title>HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC)</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2006</year><volume>22</volume><fpage>202</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1089/aid.2006.22.202</pub-id><?supplied-pmid 16478404?><pub-id pub-id-type="pmid">16478404</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>N</given-names></name><etal/></person-group><article-title>Identification and molecular characterization of subsubtype A4 in Central Africa</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2006</year><volume>22</volume><fpage>182</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1089/aid.2006.22.182</pub-id><?supplied-pmid 16478401?><pub-id pub-id-type="pmid">16478401</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>N</given-names></name><etal/></person-group><article-title>Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2008</year><volume>24</volume><fpage>315</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1089/aid.2007.0241</pub-id><?supplied-pmid 18257687?><pub-id pub-id-type="pmid">18257687</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>N</given-names></name><name><surname>Bazepeo</surname><given-names>SE</given-names></name><name><surname>Mulanga</surname><given-names>C</given-names></name><name><surname>Delaporte</surname><given-names>E</given-names></name><name><surname>Peeters</surname><given-names>M</given-names></name></person-group><article-title>Genetic characterization of eight full-length HIV type 1 genomes from the democratic republic of Congo (DRC) reveal a new subsubtype, A5, in the a radiation that predominates in the recombinant structure of CRF26-A5U</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2009</year><volume>25</volume><fpage>823</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1089/aid.2008.0283</pub-id><?supplied-pmid 19678767?><pub-id pub-id-type="pmid">19678767</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niama</surname><given-names>FR</given-names></name><etal/></person-group><article-title>CRF45-AKU, a circulating recombinant from central Africa, Is probably the common ancestor of hiv Type 1 MAL and HIV type 1 NOGIL</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2009</year><volume>25</volume><fpage>1345</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.1089/aid.2009.0169</pub-id><?supplied-pmid 20001521?><pub-id pub-id-type="pmid">20001521</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>DD</given-names></name><name><surname>Foley</surname><given-names>BT</given-names></name><name><surname>Tolzmann</surname><given-names>CA</given-names></name><name><surname>Ouma</surname><given-names>A</given-names></name><name><surname>Bremer</surname><given-names>JW</given-names></name></person-group><article-title>Complex mosaic composition of near full-length genomes of two NED (NIH-ENVA-DOD) subtype panel HIV type 1 strains, BCF-Dioum and BCF-Kita, originating from the Democratic Republic of Congo (DRC)</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2009</year><volume>25</volume><fpage>1039</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1089/aid.2009.0078</pub-id><?supplied-pmid 19795987?><pub-id pub-id-type="pmid">19795987</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djoko</surname><given-names>CF</given-names></name><etal/></person-group><article-title>High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2011</year><volume>27</volume><fpage>323</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1089/aid.2010.0201</pub-id><?supplied-pmid 20954909?><pub-id pub-id-type="pmid">20954909</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muwonga</surname><given-names>J</given-names></name><etal/></person-group><article-title>Resistance to antiretroviral drugs in treated and drug-naive patients in the democratic Republic of Congo</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2011</year><volume>57</volume><issue>Suppl 1</issue><fpage>S27</fpage><lpage>S33</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e31821f596c</pub-id><?supplied-pmid 21857282?><pub-id pub-id-type="pmid">21857282</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Kamangu, E. <italic>et al.</italic> Genetic Diversity and Antiretroviral Drug Resistance among Drug-Na&#x000ef;ve HIV Type 1 Infected Patients attending Clinics in Kinshasa, Democratic Republic of Congo. <italic>J. HIV AIDS</italic><bold>1</bold>(1)&#x000a0;(2015).</mixed-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boillot</surname><given-names>F</given-names></name><etal/></person-group><article-title>Implementation and Operational Research: Programmatic Feasibility of Dried Blood Spots for the Virological Follow-up of Patients on Antiretroviral Treatment in Nord Kivu, Democratic Republic of the Congo</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2016</year><volume>71</volume><fpage>e9</fpage><lpage>e15</lpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000000844</pub-id><?supplied-pmid 26413848?><pub-id pub-id-type="pmid">26413848</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villabona Arenas</surname><given-names>C</given-names></name><etal/></person-group><article-title>Divergent HIV-1 strains (CRF92_C2U and CRF93_cpx) co-circulating in the Democratic Republic of the Congo: Phylogenetic insights on the early evolutionary history of subtype C</article-title><source>Virus Evol.</source><year>2017</year><volume>3</volume><issue>2</issue><fpage>vex032</fpage><pub-id pub-id-type="doi">10.1093/ve/vex032</pub-id><?supplied-pmid 29250430?><pub-id pub-id-type="pmid">29250430</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubio-Garrido</surname><given-names>M</given-names></name><etal/></person-group><article-title>Utility Of POC Xpert HIV-1 tests for detection-quantification of complex HIV recombinants using dried blood spots from Kinshasa, D. R. Congo</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>5679</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-41963-y</pub-id><?supplied-pmid 30952893?><pub-id pub-id-type="pmid">30952893</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>EH</given-names></name><etal/></person-group><article-title>HIV-1 subtypes and drug resistance mutations among female sex workers varied in different cities and regions of the Democratic Republic of Congo</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><fpage>e0228670</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0228670</pub-id><?supplied-pmid 32045455?><pub-id pub-id-type="pmid">32045455</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potts</surname><given-names>KE</given-names></name><etal/></person-group><article-title>Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire</article-title><source>AIDS Res. Hum. Retroviruses</source><year>1993</year><volume>9</volume><fpage>613</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1089/aid.1993.9.613</pub-id><?supplied-pmid 8369166?><pub-id pub-id-type="pmid">8369166</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokili</surname><given-names>JLK</given-names></name><etal/></person-group><article-title>Genetic heterogeneity of HIV type 1 subtypes in Kimpese, rural democratic republic of congo</article-title><source>AIDS Res. Hum. Retroviruses</source><year>1999</year><volume>15</volume><fpage>655</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1089/088922299310953</pub-id><?supplied-pmid 10331444?><pub-id pub-id-type="pmid">10331444</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokili</surname><given-names>JLK</given-names></name><etal/></person-group><article-title>Identification of a novel clade of human immunodeficiency virus type 1 in Democratic Republic of Congo</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2002</year><volume>18</volume><fpage>817</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1089/08892220260139567</pub-id><?supplied-pmid 12167273?><pub-id pub-id-type="pmid">12167273</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Triques</surname><given-names>K</given-names></name><etal/></person-group><article-title>Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2000</year><volume>16</volume><fpage>139</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1089/088922200309485</pub-id><?supplied-pmid 10659053?><pub-id pub-id-type="pmid">10659053</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>N</given-names></name><name><surname>Mulanga-Kabeya</surname><given-names>C</given-names></name><name><surname>Nzilambi</surname><given-names>N</given-names></name><name><surname>Delaporte</surname><given-names>E</given-names></name><name><surname>Peeters</surname><given-names>M</given-names></name></person-group><article-title>Identification of a complex env subtype E HIV type 1 virus from the Democratic Republic of Congo, recombinant with A, G, H, J, K, and unknown subtypes</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2000</year><volume>16</volume><fpage>2059</fpage><lpage>2064</lpage><pub-id pub-id-type="doi">10.1089/088922200750054800</pub-id><?supplied-pmid 11153090?><pub-id pub-id-type="pmid">11153090</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradigaravand</surname><given-names>D</given-names></name><etal/></person-group><article-title>Recombination Accelerates Adaptation on a Large-Scale Empirical Fitness Landscape in HIV-1</article-title><source>PLoS Genet.</source><year>2014</year><volume>10</volume><fpage>e1004439</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1004439</pub-id><?supplied-pmid 24967626?><pub-id pub-id-type="pmid">24967626</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamangu</surname><given-names>E</given-names></name><name><surname>Kabututu</surname><given-names>Z</given-names></name><name><surname>Mvumbi</surname><given-names>L</given-names></name><name><surname>Kalala</surname><given-names>LR</given-names></name><name><surname>Mesia</surname><given-names>K</given-names></name></person-group><article-title>Genetic diversity of human immunodeficiency virus type 1 in the Democratic Republic of Congo: A review of available data</article-title><source>Int. J. Collab. Res. Intern. Med. Public Health</source><year>2013</year><volume>5</volume><fpage>295</fpage><lpage>309</lpage></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olabode</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Evidence for a recombinant origin of HIV-1 Group M from genomic variation</article-title><source>Virus Evol.</source><year>2019</year><volume>5</volume><fpage>vey039</fpage><pub-id pub-id-type="doi">10.1093/ve/vey039</pub-id><?supplied-pmid 30687518?><pub-id pub-id-type="pmid">30687518</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Garc&#x000ed;a</surname><given-names>A</given-names></name><etal/></person-group><article-title>Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47-BF) in Spain</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2010</year><volume>26</volume><fpage>827</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1089/aid.2009.0311</pub-id><?supplied-pmid 20618102?><pub-id pub-id-type="pmid">20618102</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamangu</surname><given-names>E</given-names></name><name><surname>Ikolango</surname><given-names>BB</given-names></name><name><surname>Ilunga</surname><given-names>BB</given-names></name></person-group><article-title>Evolution of Subtypes of the Human Immunodeficiency Virus Type 1 in Kinshasa over the Last 30 years: Documentary Review from 1985 to 2015</article-title><source>Mathews J. HIV/AIDS</source><year>2017</year><volume>2</volume><fpage>014</fpage></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gartner</surname><given-names>MJ</given-names></name><name><surname>Roche</surname><given-names>M</given-names></name><name><surname>Churchill</surname><given-names>MJ</given-names></name><name><surname>Gorry</surname><given-names>PR</given-names></name><name><surname>Flynn</surname><given-names>JK</given-names></name></person-group><article-title>Understanding the mechanisms driving the spread of subtype C HIV-1</article-title><source>EBioMedicine</source><year>2020</year><volume>53</volume><fpage>102682</fpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2020.102682</pub-id><?supplied-pmid 32114391?><pub-id pub-id-type="pmid">32114391</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>AS</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name><name><surname>Sanders</surname><given-names>EJ</given-names></name><name><surname>Albert</surname><given-names>J</given-names></name><name><surname>Esbj&#x000f6;rnsson</surname><given-names>J</given-names></name></person-group><article-title>Defining HIV-1 transmission clusters based on sequence data</article-title><source>AIDS</source><year>2017</year><volume>31</volume><fpage>1211</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000001470</pub-id><?supplied-pmid 28353537?><pub-id pub-id-type="pmid">28353537</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van De Vijver</surname><given-names>DAMC</given-names></name><name><surname>Boucher</surname><given-names>CAB</given-names></name></person-group><article-title>Insights on transmission of HIV from phylogenetic analysis to locally optimize HIV prevention strategies</article-title><source>Curr. Opin. HIV AIDS</source><year>2018</year><volume>13</volume><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1097/COH.0000000000000443</pub-id><?supplied-pmid 29266012?><pub-id pub-id-type="pmid">29266012</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wertheim</surname><given-names>JO</given-names></name><etal/></person-group><article-title>The global transmission network of HIV-1</article-title><source>J. Infect. Dis.</source><year>2014</year><volume>209</volume><fpage>304</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit524</pub-id><?supplied-pmid 24151309?><pub-id pub-id-type="pmid">24151309</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wertheim</surname><given-names>JO</given-names></name><etal/></person-group><article-title>Social and Genetic Networks of HIV-1 Transmission in New York City</article-title><source>PLoS Pathog.</source><year>2017</year><volume>13</volume><fpage>e1006000</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1006000</pub-id><?supplied-pmid 28068413?><pub-id pub-id-type="pmid">28068413</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosakovsky Pond</surname><given-names>SL</given-names></name><name><surname>Weaver</surname><given-names>S</given-names></name><name><surname>Leigh Brown</surname><given-names>AJ</given-names></name><name><surname>Wertheim</surname><given-names>JO</given-names></name></person-group><article-title>HIV-TRACE (transmission cluster engine): a tool for large scale molecular epidemiology of HIV-1 and other rapidly evolving pathogens</article-title><source>Mol. Biol. Evol. Evol</source><year>2018</year><volume>35</volume><fpage>1812</fpage><lpage>1819</lpage><pub-id pub-id-type="doi">10.1093/molbev/msy016</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Mulder</surname><given-names>M</given-names></name><name><surname>Holgu&#x000ed;n</surname><given-names>&#x000c1;</given-names></name></person-group><article-title>Utilidad de los dried blood spots para monitorizar la infecci&#x000f3;n por virus de la inmunodeficiencia humana en los programas de salud p&#x000fa;blica de pa&#x000ed;ses en desarrollo</article-title><source>Enferm. Infecc. Microbiol. Clin.</source><year>2013</year><volume>31</volume><fpage>100</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.eimc.2012.03.008</pub-id><?supplied-pmid 22560588?><pub-id pub-id-type="pmid">22560588</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparison of detection limits of fourth- and fifth-generation combination HIV antigen-antibody, p24 antigen, and viral load assays on diverse HIV isolates</article-title><source>J. Clin. Microbiol.</source><year>2018</year><volume>6</volume><issue>8</issue><fpage>e02045-17</fpage><pub-id pub-id-type="doi">10.1128/JCM.02045-17</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robins</surname><given-names>EB</given-names></name><name><surname>Blum</surname><given-names>S</given-names></name></person-group><article-title>Hematologic reference values for African American children and adolescents</article-title><source>Am. J. Hematol.</source><year>2007</year><volume>82</volume><fpage>611</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1002/ajh.20848</pub-id><?supplied-pmid 17177189?><pub-id pub-id-type="pmid">17177189</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="other">U.S. Food and Drug Administration (FDA). <italic>Investigations Operations Manual 2020</italic>. <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/inspections-compliance-enforcement-and">https://www.fda.gov/inspections-compliance-enforcement-and</ext-link>- (2020).</mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">World Health Organization (WHO). <italic>WHO Manual for HIV Drug Resistance Testing using Dried Blood Specimens</italic>. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/hiv/pub/drugresistance/dried_blood_spots/en/">https://www.who.int/hiv/pub/drugresistance/dried_blood_spots/en/</ext-link> (2010).</mixed-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="other">National Agency for AIDS Research (ANRS). <italic>ANRS AC11 Resistance Study Group PCR and Sequencing Procedures: HIV-1</italic>. <ext-link ext-link-type="uri" xlink:href="http://www.hivfrenchresistance.org/ANRS-procedures.pdf">https://www.hivfrenchresistance.org/ANRS-procedures.pdf</ext-link> (2015).</mixed-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamatakis</surname><given-names>A</given-names></name></person-group><article-title>RAxML version 8: A tool for phylogenetic analysis and post-analysis of large phylogenies</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><fpage>1312</fpage><lpage>1313</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu033</pub-id><?supplied-pmid 24451623?><pub-id pub-id-type="pmid">24451623</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>MN</given-names></name><name><surname>Dehal</surname><given-names>PS</given-names></name><name><surname>Arkin</surname><given-names>AP</given-names></name></person-group><article-title>FastTree 2 - Approximately maximum-likelihood trees for large alignments</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><fpage>e9490</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0009490</pub-id><?supplied-pmid 20224823?><pub-id pub-id-type="pmid">20224823</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>DP</given-names></name><etal/></person-group><article-title>RDP3: A flexible and fast computer program for analyzing recombination</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>2462</fpage><lpage>2463</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq467</pub-id><?supplied-pmid 20798170?><pub-id pub-id-type="pmid">20798170</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Masatoshi</surname><given-names>N</given-names></name></person-group><article-title>Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees</article-title><source>Mol. Biol. Evol.</source><year>1993</year><volume>10</volume><fpage>512</fpage><lpage>526</lpage><?supplied-pmid 8336541?><pub-id pub-id-type="pmid">8336541</pub-id></element-citation></ref></ref-list></back></article>